The Indian Embassy in Abu Dhabi has opened walk-in access to consular services across 16 centres throughout the UAE, easing access for the country's large Indian expatriate workforce while advising applicants to book appointments in advance.
The UK's Financial Conduct Authority has appointed Darine Obeid as its new financial attaché to the United Arab Emirates, based at the British Embassy in Abu Dhabi, deepening regulatory ties between the UK and one of the Gulf's key financial hubs.
The Jaipur Literature Festival, the world's largest free literary gathering, will expand its footprint to seven North American cities in 2026, with Los Angeles and Toronto joining the program for the first time.
Indian American professor Naren Ramakrishnan has been elected to the 2026 Virginia Academy of Science, recognised for integrating artificial intelligence with urban analytics to anticipate complex societal events.
Materials scientist Parans Paranthaman, an IIT Madras alumnus with nine R&D 100 Awards to his name since 1999, has been named the 2026 R&D 100 Researcher of the Year, one of the most prestigious honours in American applied science.
Ravi Bapna, a pioneering Indian American scholar in artificial intelligence and business analytics, has been named Dean of Santa Clara University's Leavey School of Business, tasked with deepening the school's ties across Silicon Valley and global markets.
The Financial Times' Climate & Impact Summit Latin America convened in São Paulo on August 19, bringing together global finance and sustainability leaders to discuss capital allocation and climate resilience.
Sino Jet and China Aviation Fuel have launched what they describe as China's first sustainable aviation fuel compliance service for foreign-registered business jets operating in the country.
Google, the UK Met Office and academic and government partners have launched Operation Blue Skies, a £5 million, 30-month trial to reduce aviation contrails across the North Atlantic Shanwick airspace.
Swiss biotech Vaderis Therapeutics has raised $152 million in Series B funding, led by Droia Oncology Ventures and Perceptive Advisors, to advance targeted therapies for rare vascular diseases.